The genetic deletion of FUNDC1 markedly inhibits the formation of MAMs induced by high glucose levels, consequently inhibiting regulatory pathways and reversing the progression of DCM (Wu S. et al., 2019). The gene discussed is FUNDC1; the disease is familial dilated cardiomyopathy.